Effect of ex vivo platelet inhibition on fibrinolysis in venous thromboembolism (ISTH 2026) - May 25, 2026 - Abstract #PB1715; Pres time: Jul 12, 2026; 01:45 PM - 02:45 PM; Location: Exhibition Hall- Poster Area; "Aims We aimed to investigate whether ex vivo platelet inhibition with acetylsalicylic acid (ASA) or cangrelor could enhance fibrinolysis in whole blood from patients with a recent VTE. The authors take full responsibility for the abstract content. DOI*10.1016/j.rpth.2026.104577"
Preclinical • Cardiovascular • Hematological Disorders • Respiratory Diseases • Venous Thromboembolism
|
|
Thea B. Aakjær 1; Anne L. Malte 1, 2; Erik L. Grove 2, 3; Johanne A. Højbjerg 1, 2; Julie B. Larsen 1, 2
|